MedTrace Logo

Local Application of Autologous Bone Marrow Cells for Treatment of Chronic Diabetic Ulcers

NCT00292357 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-01-18

No results posted yet for this study

Summary

Bone marrow cells were previously shown to enhance wound healing in experimental diabetes. In this pilot study, patients with chronic diabetic ulcers not healing under conventional therapy, will be treated with local application of autologous bone marrow cells.

Conditions

  • Diabetic Foot
  • Diabetes Complications

Interventions

PROCEDURE

Application of autologous bone marrow

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Peter Nawroth, MD · University of Heidelberg, Dept. Medicine 1, Germany

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00292357 on ClinicalTrials.gov